Xiu-Bao Ren

Anlotinib Versus Sunitinib as First-Line Treatment for Metastatic Renal Cell Carcinoma: A Randomized Phase II Clinical Trial

Aiping Zhou, Yuxian Bai, Yan Song et al. · The Oncologist · 2019 · 115 citations · Full text

Medicine, Oncology, Pharmacology +12

Dendritic cell-activated cytokine-induced killer cells enhance the anti-tumor effect of chemotherapy on non-small cell lung cancer in patients after surgery

Hui Li, Changli Wang, Jinpu Yu et al. · Cytotherapy · 2009 · 111 citations

Life Sciences, Oncology, Surgery +16

CD4 +CD25 + Regulatory T Cells Decreased the Antitumor Activity of Cytokine-Induced Killer (CIK) Cells of Lung Cancer Patients

Hui Li, Jin-Pu Yu, Shui Cao et al. · Journal of Clinical Immunology · 2007 · 73 citations

Life Sciences, Immunology, Oncology +16

Combined Erlotinib and Cetuximab overcome the acquired resistance to epidermal growth factor receptors tyrosine kinase inhibitor in non-small-cell lung cancer

Meng Wang, Jing Zhao, Lian-min Zhang et al. · Journal of Cancer Research and Clinical Oncology · 2012 · 28 citations · Full text

Medicine, Oncology, Pharmacology +16

Experimental study on the treatment of intracerebral glioma xenograft with human cytokine-induced killer cells

Peng Wang, Jin-Pu Yu, Song-Yuan Gao et al. · Cellular Immunology · 2008 · 24 citations

Life Sciences, Neuroscience, Oncology +16